With the global market in sight, several Asian bioventures discussed at BioJapan event recent projects, strategies and challenges in expanding their businesses in APAC. The different characteristics of policies by country and facets of venture capital funding were some of the topics when speakers talked about “what's the ideal collaboration between Asian bioventures?”
The challenges and opportunities of running a bioventure depend on which country you’re based in and which market you’re focused on. And it matters too for large pharmaceutical firms in search for the next novel R&D seeds across the APAC region.
At the recent BioJapan 2022 event, five speakers from bioventures and large pharma firms in South Korea, Japan and Taiwan...